Our Company

Alex Advani has spent his consulting career applying his deep analytical experience and skills to biopharmaceutical strategy. His work includes launch strategy, site of care and account profiling, opportunity assessment, indication prioritization, and portfolio development strategy. He has deep expertise in multiple therapeutic areas such as solid tumors and hematology/oncology, genetic and rare disease, and immunology. Alex received Ph.D. and Master’s degrees in Genetics, Genomics, and Systems Biology from the University of Chicago and a B.A. in Biology from Duke University.

As a consultant, Amanda has focused on the therapeutic areas of oncology and rare neurological diseases. She has experience in the evolution of medical devices and development of specialty pharmacy drug programs. Amanda’s extensive analytical experience has been applied to secondary and primary research. Her previous work includes competitive assessments, development of treatment landscapes, as well as pipeline and clinical development analyses. Prior to consulting, Amanda worked as a postdoc at the University of Chicago where she developed a CRISPR pipeline for human cell culture systems. Her PhD research in cell and structural biology was performed at EMBL in Heidelberg, Germany. Amanda has earned a BS/MS in Chemistry at Stevens Institute of Technology in Hoboken NJ.

Amy joined the LifeSci Consulting team in August 2023. Her work includes cost optimization, project management, change management, and operational transformation as well as helping clients to optimize their processes, navigate change, and manage costs. Before joining LifeSci, Amy worked at 4C Associates within the Life Sciences. During this time, she worked on process optimization, procurement excellence, and cost optimization projects for large pharmaceutical clients both in Europe and the US. Prior to her career in consulting Amy worked in in-house procurement, focusing on strategic sourcing within the marketing category. She has a degree in Biological Sciences and experience working within Research and Development and Drug Discovery.

Ana joined LifeSci Consulting as an Analyst in July 2024 after interning during the summer of 2023. Before joining LifeSci, Ana interned at Proteus by Seqens, aiding in commercializing biocatalytic processes and C4 Therapeutics, focusing on literature curation for targets such as BRAF, EGFR, and IKZF. She also interned at Triton Bio, where she conducted research and created schematic models for the parasite cryptosporidium, and at Eurofins Food Integrity and Innovation, where she assisted in researching and developing food and beverage products.

Ana graduated from Yale University with a B.S. in Biomedical Engineering. While at Yale, she carried out research in the Kyriakides Lab at the Yale School of Medicine and Pathology, working on TSP-2 null hydrogels for volumetric muscle loss. She was also a member of the Varsity Women's Lacrosse team and volunteered for Team Impact, a non-profit organization matching children with long-term illness or disability with college sports teams.

Anna joined the LifeSci Consulting team in July 2023. Her work includes go-to-market strategy, corporate strategy and operating model design and implementation. Prior to joining LifeSci, Anna was a Senior Consultant within the Deloitte Strategy and Business Design team. While there, Anna worked across a range of projects including corporate strategy design and execution, strategic transformation, market entry, commercial due diligence, post-merger integration as well as service design. Anna has diverse experience working with clients across life sciences, healthcare, energy, media and banking industries. Anna has a Bachelor of Commerce majoring in Supply Chain and Operations Management and Marketing, as well as a Postgraduate Degree in Journalism.

Anna joined the LifeSci Consulting team in July 2023 with a strong foundation in neuroscience and a proven track record in life sciences consulting. With a Ph.D. in Biomedical Sciences and a concentration in Neuroscience, Anna brings a deep understanding of the intricate workings of the human brain and its implications for healthcare innovation. Leveraging this expertise, she has successfully advised numerous organizations within the life sciences industry in her prior position at Alacrita Consulting, providing strategic insights, market analysis, and customized solutions. With an unwavering commitment to delivering actionable recommendations and fostering collaborative relationships, Anna is poised to make a significant impact as a consultant with LifeSci. Anna received her Ph.D. from the University of Massachusetts Medical School and her B.S. in Biotechnology from Worcester Polytechnic Institute.

Bert has spent his career in biopharmaceutical strategy consulting. Bert's work includes opportunity assessments, commercial strategy, and asset valuations across diverse therapeutic areas. Prior to LifeSci, he was an Engagement Manager at Trinity Life Sciences. Bert is a graduate of UC Berkeley, where he received a BA in Public Health with a focus in Health Economics.

Blake joined LifeSci in March 2022 with over 8 years of academic and industry research experience spanning multiple disciplines including neuroscience (aging, Alzheimer’s Disease, Parkinson’s Disease, and other movement disorders), cardiovascular disease, and genetics. He specialized in the use of imaging techniques (MRI, fMRI, PET) to study the mechanisms underlying degenerative age-related processes in the body. Prior to joining LifeSci, Blake received his B.S. degree in Biomedical Engineering from Rensselaer Polytechnic Institute (RPI) in 2016. He next matriculated in the Neuroscience Graduate Program (NGP) in the Wake Forest School of Medicine and earned his Ph.D. in Neuroscience in 2021. He then completed a postdoctoral research fellowship in the Vanderbilt Memory and Alzheimer’s center.